The MTPConnect Podcast MTPConnect
-
- Science
The MTPConnect Podcast Series connects with the people and the issues behind Australia’s growing medical technologies, biotechnologies and pharmaceuticals sector.
-
The Challenge: A $5 Million Competition to Reimagine Health Care in Western Australia’s Pilbara Region
Back in 2022, the Government of Western Australia issued a global challenge for a world-leading medical research and innovation solution to resolve a pressing problem of health service delivery in the remote Pilbara region.Ten projects were selected as finalists and given 12 months proof of concept funding to deliver their solution on the ground in the Pilbara. With the competition ending in October, the best solution will be selected to take home the $5 million prize supported by WA governme...
-
Australian Stroke and Heart Research Accelerator – driving clinical impact and entrepreneurship
The Australian Stroke & Heart Research Accelerator (ASHRA) was established in early 2022 as part of the Targeted Translation Research Accelerator – a program delivered by MTPConnect for the Medical Research Future Fund.This is a research centre with a difference. Lead by Australia’s foremost heart and stroke researchers, ASHRA is aiming to transform the field of cardiovascular and stroke research in Australia by bringing a new sector-wide focus on clinical impact and entrepreneurship.ASHR...
-
From Mines to Medicines - Australia Poised for a Radiopharmaceuticals Revolution
Radiopharmaceuticals are precision nuclear medicines used for medical imaging and treatment that allow doctors to diagnose and deliver targeted therapies for diseases such as cancer. A new discussion paper from MTPConnect, ‘From Mines to Medicines. Australia’s Radiopharmaceuticals Future’ reveals how Australia is ready to play a leading role in the rise of the global radiopharmaceutical industry, as advanced therapies drive significant investment and rapid expansion. South Australia is i...
-
Argenica Therapeutics Trials New Treatment to Protect the Brain after a Stroke
Perth- based biotech Argenica Therapeutics is developing therapies to treat stroke and other neurological conditions. A new neuroprotective peptide treatment is now being tested for ischaemic stroke patients presenting to emergency departments at 10 hospitals around Australia and is expected to improve patient outcomes by protecting the brain tissue from dying until blood flow can be restored. CEO and Managing Director Dr Liz Dallimore joins hosts Caroline Duell and WA Life Sciences Inno...
-
SA Insights: Funding Programs that Drive Australia's Healthtech Innovations
Innovators have told us that funding is important but difficult to navigate. The Australian Government is committed to investing billions of dollars into medical research and industry growth, cultivating a culture of translation and improving health for all Australians. So MTPConnect’s Adelaide Intermediary Program kicked off its first SA Insights event in 2024 by bringing the Commonwealth funders together to offer invaluable insights, advice, and inspiration to over 200 guests.This episode t...
-
CTCM Connects Medtech Trailblazers
MTPConnect’s Clinical Translation and Commercialisation Medtech (CTCM) program held its first annual Symposium in Sydney recently, bringing together all 11 companies from around Australia who are recipients of CTCM funding to develop new medical devices to improve health and wellbeing.In this episode, host Caroline Duell meets some of these Australian trailblazers - Eudaemon Technologies, CathRx, Ventora Medical, LBT Innovations, and 4DMedical, to find out more about their innovations and how...